• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比索洛尔治疗血压控制不佳患者后的血流动力学时间变化

Temporal haemodynamic changes after bisoprolol treatment in patients with uncontrolled hypertension.

作者信息

Zeng Weiwei, Tomlinson Brian

机构信息

Department of Pharmacy, Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, China.

Faculty of Medicine, Macau University of Science and Technology, Taipa, Macau, China.

出版信息

Ann Transl Med. 2021 Jun;9(11):923. doi: 10.21037/atm-21-1796.

DOI:10.21037/atm-21-1796
PMID:34350238
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8263854/
Abstract

BACKGROUND

Anti-hypertensive drugs are widely used to control blood pressure, yet their effects on haemodynamics, especially in Chinese populations, and the potential for non-invasive methods to monitor these changes, are poorly understood. This study aimed to determine the early and late effects of bisoprolol treatment on blood pressure, cardiac output (CO), stroke volume (SV), heart rate (HR), systematic vascular resistance (SVR), and inotropy measured in Chinese patients with hypertension.

METHODS

Twelve Chinese subjects (median age: 55 years, interquartile range: 52-58 years; 33% male) with uncontrolled hypertension were recruited at the Prince of Wales Hospital in Hong Kong and haemodynamic measurements were assessed using a non-invasive Ultrasonic Cardiac Output Monitor (USCOM). Seven hourly measurements were taken before and after bisoprolol 2.5 mg on day 1 (T0 to T6), and in nine patients this was repeated six weeks later (TF0 to TF6). Any BP change of 5 mmHg was considered clinically significant and P<0.05 was considered statistically significant.

RESULTS

On day 1 (N=12), there was a significant drop in median CO [4.9 (4.7-5.6) 3.8 (3.3-4.7) L/m, P<0.0001] associated with a compensatory increase in SVR [1,698.1 (1,584.6-1,894.3) 2,222.6 (1,777.4-2,712.5) d·s·cm, P<0.0001] at T2. The median dBP {92 [87-95] 86 [79-89] mmHg, P=0.0002} and MAP {110 [104-114] 104 [101-109] mmHg, P=0.038} reduced significantly 6 hours after bisoprolol treatment. Except for HR, all other measured haemodynamics returned to baseline at T6. On week 6 (N=9), SVR was generally reduced, but major parallel swings in CO and SVR were still evident. All patients showed a trend to lower blood pressure, SVR, and inotropy (P<0.05), but HR, SV, and CO returned to baseline values after 6 weeks treatment (P>0.05).

CONCLUSIONS

The acute haemodynamic changes between 6 hours of the first dose and the dose after 6 weeks of bisoprolol treatment are similar. Long-term therapy can effectively reduce blood pressure by reducing SVR.

摘要

背景

抗高血压药物被广泛用于控制血压,然而其对血流动力学的影响,尤其是在中国人群中的影响,以及非侵入性方法监测这些变化的潜力,目前仍知之甚少。本研究旨在确定比索洛尔治疗对中国高血压患者血压、心输出量(CO)、每搏输出量(SV)、心率(HR)、全身血管阻力(SVR)和心肌收缩力的早期和晚期影响。

方法

在香港威尔士亲王医院招募了12名血压控制不佳的中国受试者(中位年龄:55岁,四分位间距:52 - 58岁;33%为男性),并使用非侵入性超声心输出量监测仪(USCOM)评估血流动力学指标。在第1天给予2.5 mg比索洛尔前后(T0至T6)每小时测量一次,共测量7次,其中9名患者在6周后重复测量(TF0至TF6)。血压变化5 mmHg被认为具有临床意义,P<0.05被认为具有统计学意义。

结果

在第1天(N = 12),T2时中位CO显著下降[4.9(4.7 - 5.6)对3.8(3.3 - 4.7)L/m,P<0.0001],同时SVR代偿性增加[1,698.1(1,584.6 - 1,894.3)对2,222.6(1,777.4 - 2,712.5)d·s·cm,P<0.0001]。比索洛尔治疗6小时后,中位舒张压{92 [87 - 95]对86 [79 - 89] mmHg,P = 0.0002}和平均动脉压{110 [104 - 114]对104 [101 - 109] mmHg,P = 0.038}显著降低。除HR外,所有其他测量的血流动力学指标在T6时恢复至基线水平。在第6周(N = 9),SVR总体下降,但CO和SVR的主要平行波动仍然明显。所有患者的血压、SVR和心肌收缩力均有下降趋势(P<0.05),但治疗6周后HR、SV和CO恢复至基线值(P>0.05)。

结论

比索洛尔治疗第1剂后6小时至6周后剂量之间的急性血流动力学变化相似。长期治疗可通过降低SVR有效降低血压。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bed/8263854/c3dd71206747/atm-09-11-923-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bed/8263854/dca8788ecb7d/atm-09-11-923-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bed/8263854/c3dd71206747/atm-09-11-923-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bed/8263854/dca8788ecb7d/atm-09-11-923-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bed/8263854/c3dd71206747/atm-09-11-923-f2.jpg

相似文献

1
Temporal haemodynamic changes after bisoprolol treatment in patients with uncontrolled hypertension.比索洛尔治疗血压控制不佳患者后的血流动力学时间变化
Ann Transl Med. 2021 Jun;9(11):923. doi: 10.21037/atm-21-1796.
2
Age-specific non-invasive transcutaneous Doppler ultrasound derived haemodynamic reference ranges in elderly Chinese adults.中国老年成年人特定年龄的无创经皮多普勒超声血流动力学参考范围
BBA Clin. 2014 Sep 28;2:48-55. doi: 10.1016/j.bbacli.2014.09.002. eCollection 2014 Dec.
3
Haemodynamic responses to physical activity and body posture during everyday life.日常生活中对身体活动和体位的血流动力学反应。
J Hypertens. 2004 Jan;22(1):89-96. doi: 10.1097/00004872-200401000-00017.
4
Haemodynamic Influences of Bisoprolol in Hypertensive Middle-Aged Men: A Double-Blind, Randomized, Placebo-Controlled Cross-Over Study.比索洛尔对中年高血压男性血流动力学的影响:一项双盲、随机、安慰剂对照的交叉研究。
Basic Clin Pharmacol Toxicol. 2017 Aug;121(2):130-137. doi: 10.1111/bcpt.12771. Epub 2017 May 3.
5
PP097. Cardiac output and systemic vascular resistance in normal pregnancy and in control non-pregnant women.PP097. 正常妊娠女性与对照非妊娠女性的心输出量和全身血管阻力。
Pregnancy Hypertens. 2012 Jul;2(3):292-3. doi: 10.1016/j.preghy.2012.04.208. Epub 2012 Jun 13.
6
Haemodynamic changes during craniotomy monitored by a bioimpedance plethysmographic noninvasive cardiac output monitor.通过生物阻抗体积描记无创心输出量监测仪监测开颅手术期间的血流动力学变化。
J Clin Monit Comput. 2009 Jun;23(3):157-61. doi: 10.1007/s10877-009-9166-z. Epub 2009 Feb 11.
7
One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study.比索洛尔与氯沙坦对近期诊断的高血压患者的一年肾脏和心脏影响:一项随机双盲研究。
Clin Drug Investig. 2009;29(9):591-600. doi: 10.2165/11315250-000000000-00000.
8
Contribution of systemic blood flow to untreated or inadequately controlled systolic--diastolic or isolated systolic hypertension in a community sample of African ancestry.社区内非洲裔人群样本中,全身血流对未经治疗或控制不佳的收缩期-舒张期或单纯收缩期高血压的影响。
J Hypertens. 2021 Mar 1;39(3):526-537. doi: 10.1097/HJH.0000000000002635.
9
Feasibility of preclinical cardiac output and systemic vascular resistance in HEMS in thoracic pain--the ultrasonic cardiac output monitor.院前急救中胸痛患者使用超声心输出量监测仪测量心输出量及全身血管阻力的可行性研究
Air Med J. 2006 Nov-Dec;25(6):270-5. doi: 10.1016/j.amj.2006.08.005.
10
Haemodynamic responses of wearing low-pressure sports compression tights during an orthostatic challenge in healthy individuals.健康个体在直立挑战期间穿着低压运动压缩紧身衣的血液动力学反应。
J Sci Med Sport. 2018 Oct;21(10):1062-1067. doi: 10.1016/j.jsams.2017.12.004. Epub 2017 Dec 15.

本文引用的文献

1
Population pharmacokinetic analysis of bisoprolol in type 2 diabetic patients with hypertension.2 型糖尿病合并高血压患者比索洛尔的群体药代动力学分析。
Eur J Clin Pharmacol. 2020 Nov;76(11):1539-1546. doi: 10.1007/s00228-020-02937-6. Epub 2020 Jun 25.
2
Choosing among β-blockers in heart failure patients according to β-receptors' location and functions in the cardiopulmonary system.根据β受体在心肺系统中的位置和功能,在心衰患者中选择β受体阻滞剂。
Pharmacol Res. 2020 Jun;156:104785. doi: 10.1016/j.phrs.2020.104785. Epub 2020 Mar 26.
3
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.
《心脏病与卒中统计-2020 更新:来自美国心脏协会的报告》。
Circulation. 2020 Mar 3;141(9):e139-e596. doi: 10.1161/CIR.0000000000000757. Epub 2020 Jan 29.
4
Accuracy and precision of USCOM versus transthoracic echocardiography before and during pregnancy.USCOM 与经胸超声心动图在妊娠前后的准确性和精密度比较。
Pregnancy Hypertens. 2019 Jul;17:138-143. doi: 10.1016/j.preghy.2019.04.003. Epub 2019 Apr 16.
5
Role of Beta-blockers in Cardiovascular Disease in 2019.2019年β受体阻滞剂在心血管疾病中的作用
Rev Esp Cardiol (Engl Ed). 2019 Oct;72(10):844-852. doi: 10.1016/j.rec.2019.04.014. Epub 2019 Aug 8.
6
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension.2018年欧洲高血压学会和欧洲心脏病学会动脉高血压管理实践指南:欧洲高血压学会/欧洲心脏病学会动脉高血压管理特别工作组
J Hypertens. 2018 Dec;36(12):2284-2309. doi: 10.1097/HJH.0000000000001961.
7
Hypertension.高血压。
Nat Rev Dis Primers. 2018 Mar 22;4:18014. doi: 10.1038/nrdp.2018.14.
8
Initial Treatment of Hypertension.高血压的初始治疗
N Engl J Med. 2018 Feb 15;378(7):636-644. doi: 10.1056/NEJMcp1613481.
9
Pharmacological intervention in hypertension using beta-blockers: Real-world evidence for long-term effectiveness.β受体阻滞剂在高血压治疗中的药物干预:长期有效性的真实世界证据。
Pharmacol Res. 2018 Apr;130:191-197. doi: 10.1016/j.phrs.2018.01.010. Epub 2018 Jan 31.
10
Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).中国高血压的患病率、知晓率、治疗率和控制率:一项基于人群筛查研究的 170 万成年人数据(中国高血压调查)。
Lancet. 2017 Dec 9;390(10112):2549-2558. doi: 10.1016/S0140-6736(17)32478-9. Epub 2017 Nov 5.